Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
COSCIENS Biopharma (GB:0UGB)
LSE:0UGB
Holding GB:0UGB?
Track your performance easily
0UGB Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$5.01 - C$201.00
Previous CloseC$5.01
Volume0.00
Average Volume (3M)239.00
Market Cap
C$16.20M
Enterprise Value-C$19.12M
Total Cash (Recent Filing)$27.80M
Total Debt (Recent Filing)$1.69M
Price to Earnings (P/E)―
Beta0.65
Next Earnings
Nov 07, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-39.25
Shares Outstanding1,793,009
10 Day Avg. Volume16
30 Day Avg. Volume239
Standard Deviation1.63
R-Squared0.02
Alpha0.15
Financial Highlights & Ratios
Price to Book (P/B)0.55
Price to Sales (P/S)0.86
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-7.76
Enterprise Value/Gross Profit-4.25
Enterprise Value/Ebitda1.13
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
COSCIENS Biopharma News
PremiumCompany Announcements
COSCIENS Biopharma Advances Merger and Seeks New Leadership
PremiumCompany Announcements
COSCIENS Biopharma’s Unexpected Trial Outcomes
0UGB FAQ
What was COSCIENS Biopharma’s price range in the past 12 months?
COSCIENS Biopharma lowest share price was C$5.01 and its highest was C$201.00 in the past 12 months.
What is COSCIENS Biopharma’s market cap?
Currently, no data Available
When is COSCIENS Biopharma’s upcoming earnings report date?
COSCIENS Biopharma’s upcoming earnings report date is Nov 07, 2024 which is in 42 days.
How were COSCIENS Biopharma’s earnings last quarter?
Currently, no data Available
Is COSCIENS Biopharma overvalued?
According to Wall Street analysts COSCIENS Biopharma’s price is currently Overvalued.
Does COSCIENS Biopharma pay dividends?
COSCIENS Biopharma does not currently pay dividends.
What is COSCIENS Biopharma’s EPS estimate?
COSCIENS Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does COSCIENS Biopharma have?
COSCIENS Biopharma has 3,115,974 shares outstanding.
What happened to COSCIENS Biopharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of COSCIENS Biopharma?
Currently, no hedge funds are holding shares in GB:0UGB
---
COSCIENS Biopharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.44%
12-Months-Change
Fundamentals
Return on Equity
-81.71%
Trailing 12-Months
Asset Growth
-38.01%
Trailing 12-Months
Company Description
COSCIENS Biopharma
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC.
---
0UGB Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering 0UGB
1 Year
1 Year Success Rate
0/4 ratings generated profit
1 Year Average Return
-43.20%
reiterated a buy rating 11 months ago
Copying Boobalan Pachaiyappan's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -43.20% per trade.
---